NORDIC BIOTECH INCENTIVE ApS: Financial statements 2024
CVR: 26277779
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NORDIC BIOTECH INCENTIVE ApS (CVR 26277779) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -243,054 and a net result of DKK 4,871,034 compared with DKK -35,522 the year before. Equity in the 2024 report amounted to DKK 6,553,968. The solvency ratio was 96.1%.
- Gross Profit
- DKK -243,054
- Profit/Loss
- DKK 4,871,034
- Equity
- DKK 6,553,968
- Total Assets
- DKK 6,821,282
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -243K | 4.9M | 6.6M | - |
| 2023 | - | 133K | -36K | 1.7M | - |
| 2022 | - | -18K | -2.3M | 1.7M | 0 |
| 2021 | - | -15K | -338K | 4M | 0 |
| 2020 | - | -17K | -87K | 4.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2023. Gross profit came to DKK 133,444, and the net result was DKK -35,522.
About NORDIC BIOTECH INCENTIVE ApS
NORDIC BIOTECH INCENTIVE ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company has been dissolved on 30 September 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.